Is International Flavors & Fragrances Inc. (IFF) the Best Basic Materials Stock To Buy Now?
🏆 International Flavors & Fragrances (IFF) ranks 10th on Insider Monkey's list of the best basic materials stocks to buy now.
📈 The company achieved record second-quarter 2024 adjusted EBITDA growth of 15% year-over-year driven by volume expansion.
💰 IFF has raised its full-year sales guidance to $11.1 billion–$11.3 billion, up from the previous range of $10.8 billion–$11.1 billion.
📊 Adjusted operating EBITDA is projected to increase to a range of $2.1 billion–$2.17 billion for the full year.
🧬 The health and biosciences segment accounts for nearly 25% of total revenue, leading in probiotics and enzymes globally.
🍫 About half of IFF's sales come from its nourish business, which includes plant-based proteins and texturants.
🏭 Major acquisitions include DuPont's nutrition and biosciences businesses (2021) and Frutarom (2018).
⚠️ Shareholder value previously suffered due to overpayment for the Frutarom and DuPont Nutrition Sciences acquisitions.
📉 The broader basic materials sector saw a 10.40% year-to-date return, with specialty chemicals holding 41.75% market weight.
🔬 Sustainability initiatives include circular ecosystems, bio-based feedstocks, and chemical recycling to reduce emissions.
🏛️ Millennium Management is the largest hedge fund stakeholder with 4,320,107 shares worth $411.32 million as of Q2 2024.
🌍 IFF collaborates with clients to provide unique solutions across food, beverage, health, and personal care industries.
- IFF reported record second-quarter 2024 adjusted EBITDA growth of 15% year-over-year driven by high single-digit volume growth.
- The company has raised its full-year sales guidance to $11.1 billion–$11.3 billion, an increase from the prior range of $10.8 billion–$11.1 billion.
- Adjusted operating EBITDA is expected to rise to a range of $2.1 billion–$2.17 billion for the full year.
- IFF is the world's largest specialty ingredient producer with a diverse portfolio across food, beverage, health, and personal care sectors.
- The health and biosciences segment accounts for nearly 25% of total revenue and leads globally in probiotics and enzymes.
- Millennium Management holds a significant stake of 4.3 million shares valued at $411.32 million as of Q2 2024, indicating strong institutional confidence.
- Shareholder value previously suffered due to overpayment for the acquisitions of Frutarom and DuPont Nutrition Sciences.
- The broader basic materials sector is cyclical and tied to economic conditions, with recession worries affecting market sentiment.
- China's shift toward electric arc furnace steel production may reduce long-term demand for iron ore, impacting related supply chains.